Abingworth LLP - 10%+ Owner at Jasper Therapeutics, Inc.

Issuer-level insider activity

Role
10%+ Owner
Issuer ticker
JSPR, JSPRW on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Abingworth LLP since 26 Aug 2025

Reported holdings for Abingworth LLP in Jasper Therapeutics, Inc.

Form 4 holding 10%+ Owner

Jasper Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
78,045
Estimated value
Report date
21 Mar 2022
Price
Ownership
Indirect
Underlying class
Voting Common Stock
Underlying amount

Transaction history for Abingworth LLP in Jasper Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .